These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 65226)

  • 1. Experimental studies on the antiarrhythmic action of a lidocaine analog.
    Okuma K; Sugiyama S; Wada M; Sugenoya J; Niimi N
    Cardiology; 1976; 61(4):289-97. PubMed ID: 65226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A specific effect of lidocaine and tocainide on ventricular conduction of mid-range extrasystoles.
    Man RY; Dresel PE
    J Cardiovasc Pharmacol; 1979; 1(3):329-42. PubMed ID: 94400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antiarrhythmic properties of BL-3677A.
    Buyniski JP; Gardier RW
    J Pharmacol Exp Ther; 1974 Aug; 190(2):289-99. PubMed ID: 4449041
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tetrodotoxin potentiation of the antiarrhythmic action of lidocaine in the late stage of experimental myocardial infarct].
    Rozenshtraukh LV; Aniukhovskiĭ EP; Beloshapko GG
    Biull Eksp Biol Med; 1981; 91(1):38-40. PubMed ID: 6163491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine.
    El-Sherif N; Scherlag BJ; Lazzara R; Hope RR
    Circulation; 1977 Sep; 56(3):395-402. PubMed ID: 69503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lidocaine on ventricular conduction in acutely ischemic dog hearts.
    Carson DL; Dresel PE
    J Cardiovasc Pharmacol; 1983; 5(3):357-63. PubMed ID: 6191132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current understanding of lidocaine as an antiarrhythmic agent: a review.
    Anderson JL
    Clin Ther; 1984; 6(2):125-41. PubMed ID: 6200230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of lidocaine on conduction of extrasystoles in the normal canine heart.
    Carson DL; Dresel PE
    J Cardiovasc Pharmacol; 1981; 3(5):924-35. PubMed ID: 6168860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs.
    Krejcy K; Krumpl G; Todt H; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug; 346(2):213-8. PubMed ID: 1448183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and electrophysiologic studies of R61748 (transcainide): a new class Ic antiarrhythmic drug.
    Yang X; Yu T; Kesteloot H
    Acta Cardiol; 1992; 47(1):43-56. PubMed ID: 1378674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
    Harrison DC; Alderman EL
    Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
    [No Abstract]   [Full Text] [Related]  

  • 13. Facilitation of reentry by lidocaine in canine myocardial infarction.
    Fazekas T; Scherlag BJ; Mabo P; Patterson E; Lazzara R
    Acta Physiol Hung; 1994; 82(3):201-13. PubMed ID: 7717083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studying the mechanism of antiarrhythmic action of a tertiary derivative of lidocaine].
    Blinov DS; Kostin IaV; Skachilova SIa
    Eksp Klin Farmakol; 2004; 67(3):18-20. PubMed ID: 15341061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lignocaine on intramyocardial conduction in nonischaemic and ischaemic canine myocardium.
    Levites R; Haft JJ; Venkatachalapathy D
    Cardiovasc Res; 1976 Nov; 10(6):687-90. PubMed ID: 991167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of lidocaine on reentrant ventricular rhythms in the subacute myocardial infarction period in dogs.
    Yin H; el-Sherif N; Caref EB; Ndrepepa G; Levin R; Isber N; Stergiopolus K; Assadi MA; Gough WB; Restivo M
    Am J Physiol; 1997 Jan; 272(1 Pt 2):H299-309. PubMed ID: 9038950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mexiletine on reperfusion-induced ventricular arrhythmias: comparison with lidocaine.
    Bonaduce D; Ferrara N; Abete P; Longobardi G; Leosco D; Canonico V; Morgano G; Rengo F
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):19-29. PubMed ID: 3827408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiarrhythmic and hemodynamic actions of alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine (MK-251).
    Torchiana ML; Stone CA; Wenger HC; Evans R; Lagerquist B; O'Malley T
    J Pharmacol Exp Ther; 1975 Aug; 194(2):415-26. PubMed ID: 1151767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The combined effect of 2 first-line anti-arrhythmia drugs on the conduction velocity of myocardial stimulation].
    Nesterenko VV; Aniukhovskiĭ EP; Starmer ChF; Beloshapko GG; Ivanovich T; Bugriĭ EM; Mazaev AV; Rozenshtraukh LV
    Kardiologiia; 1990 Mar; 30(3):81-7. PubMed ID: 2381129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
    Murakawa Y; Toda I; Nozaki A; Kawakubo K; Sugimoto T
    Cardiology; 1989; 76(1):58-66. PubMed ID: 2468414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.